# Exploration of potential biomarkers and immune cell infiltration characteristics for peripheral atherosclerosis in sjögren’s syndrome based on comprehensive bioinformatics analysis and machine learning

**Authors:** Chunjiang Liu, Yuan Wang, Lina Zhou, Feifei Cai, Xiaoqi Tang, Liying Wang, Xiang Zhang

PMC · DOI: 10.3389/fgene.2025.1546315 · Frontiers in Genetics · 2025-07-30

## TL;DR

This study identifies key genes and immune cell patterns linked to atherosclerosis in Sjögren’s syndrome patients using bioinformatics and machine learning.

## Contribution

The study introduces three hub genes (CCL4, CSF1R, MX1) and a predictive nomogram for peripheral atherosclerosis in Sjögren’s syndrome.

## Key findings

- 135 differentially expressed genes were identified in peripheral atherosclerosis of Sjögren’s syndrome patients.
- CCL4, CSF1R, and MX1 were highlighted as key genes with high predictive accuracy (AUC: 0.971).
- Immune cell infiltration and ssGSEA analysis revealed biological mechanisms linking Sjögren’s syndrome to atherosclerosis.

## Abstract

Sjögren’s syndrome (SS) is an autoimmune disorder impacting exocrine glands, while peripheral atherosclerosis (PA) demonstrates a close link to inflammation. Despite a notable rise in atherosclerosis risk among SS patients in prior investigations, the precise mechanisms remain elusive.

A comprehensive analysis was conducted on seven microarray datasets (GSE7451, GSE23117, GSE143153, GSE28829, GSE100927, GSE159677, and GSE40611). The LIMMA package, in conjunction with weighted gene co-expression network analysis (WGCNA), provides a robust method for identifying differentially expressed genes (DEGs) associated with peripheral atherosclerosis (PA) in Sjögren’s syndrome (SS). Subsequently, machine learning algorithms and protein-protein interaction (PPI) network analysis were employed to further investigate potential predictive genes. These findings were utilized to construct a nomogram and a receiver operating characteristic (ROC) curve, which assessed the predictive accuracy of these genes in PA patients with SS. Additionally, extensive analyses of immune cell infiltration and single-sample gene set enrichment analysis (ssGSEA) were conducted to elucidate the underlying biological mechanisms.

Using the LIMMA package and WGCNA, 135 DEGs associated with PA in SS were identified. PPI network analysis revealed 17 candidate hub genes. The intersection of gene sets identified by three distinct machine learning algorithms highlighted CCL4, CSF1R, and MX1 as key DEGs. ROC analysis and nomogram construction demonstrated their high predictive accuracy (AUC: 0.971, 95% CI: 0.941–1.000). Analysis of immune cell infiltration showed a significant positive correlation between these hub genes and dysregulated immune cells. Additionally, ssGSEA provided critical biological insights into the progression of PA in SS.

This study systematically identified three promising hub genes (CCL4, CSF1R, and MX1) and developed a nomogram for predicting PA in SS. Analysis of immune cell infiltration demonstrated that dysregulated immune cells significantly contribute to the progression of PA. Additionally, ssGSEA analysis offered important insights into the mechanisms by which SS leads to PA.

## Linked entities

- **Genes:** CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351], CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 1436], MX1 (MX dynamin like GTPase 1) [NCBI Gene 4599]

## Full-text entities

- **Genes:** SIGLEC5 (sialic acid binding Ig like lectin 5) [NCBI Gene 8778] {aka CD170, CD33L2, OB-BP2, OBBP2, SIGLEC-5}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, DHRS9 (dehydrogenase/reductase 9) [NCBI Gene 10170] {aka 3-alpha-HSD, 3ALPHA-HSD, RDH-TBE, RDH15, RDHL, RDHTBE}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, PTPRJ (protein tyrosine phosphatase receptor type J) [NCBI Gene 5795] {aka CD148, DEP1, HPTP eta, HPTPeta, R-PTP-ETA, R-PTP-J}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, IL34 (interleukin 34) [NCBI Gene 146433] {aka C16orf77, IL-34}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL21 (interleukin 21) [NCBI Gene 59067] {aka CVID11, IL-21, Za11}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, MX1 (MX dynamin like GTPase 1) [NCBI Gene 4599] {aka IFI-78K, IFI78, MX, MxA, lncMX1-215}, MPO (myeloperoxidase) [NCBI Gene 4353], TRIM21 (tripartite motif containing 21) [NCBI Gene 6737] {aka RNF81, RO52, Ro/SSA, SSA, SSA1, TRIM21/Ro52}, CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 1436] {aka BANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}
- **Diseases:** endothelial dysfunction (MESH:D014652), immune disorders (MESH:D007154), vascular stenosis or occlusion (MESH:D008641), ischemia (MESH:D007511), inflammatory cytokines (MESH:D000080424), autoimmune conditions (MESH:D001327), CL (MESH:D002971), SS (MESH:D012859), viral myocarditis (MESH:D014777), atherosclerotic plaques (MESH:D058226), systemic lupus erythematosus (MESH:D008180), cardiovascular and peripheral vascular disorders (MESH:D016491), stroke (MESH:D020521), systemic vasculitis (MESH:D056647), autoimmune rheumatic diseases (MESH:D012216), Inflammation (MESH:D007249), Atherosclerosis (MESH:D050197), necrosis (MESH:D009336), cardiovascular and cerebrovascular diseases (MESH:D002318), arteriosclerosis (MESH:D001161), rheumatoid arthritis (MESH:D001172), endothelial injury (MESH:D057772), influenza A (MESH:D007251)
- **Chemicals:** PA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** SS-PA — Homo sapiens (Human), Sjogren syndrome, Transformed cell line (CVCL_A2JM)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12343227/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12343227/full.md

## References

77 references — full list in the complete paper: https://tomesphere.com/paper/PMC12343227/full.md

---
Source: https://tomesphere.com/paper/PMC12343227